{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:10:52Z","timestamp":1760044252330},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/bf03169123","type":"journal-article","created":{"date-parts":[[2009,10,28]],"date-time":"2009-10-28T03:52:33Z","timestamp":1256701953000},"page":"14-20","source":"Crossref","is-referenced-by-count":10,"title":["Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake"],"prefix":"10.1007","volume":"174","author":[{"given":"L.","family":"Grogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tiernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Geogeghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03169123_CR1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ije\/25.1.204","volume":"25","author":"F Bolumar","year":"1996","unstructured":"Bolumar F, Hernandez-Aguado I., Ferrer L et al. Prevalence of antibodies to Hepatitis C in a population of intravenous drug users in Valencia, Spain, 1990\u20132.Int J Epidemiol 1996: 25: 204\u2013209.","journal-title":"Int J Epidemiol"},{"key":"BF03169123_CR2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/oxfordjournals.epirev.a036161","volume":"16","author":"O Levine","year":"1999","unstructured":"Levine O, Vlahov D, Nelson K. Epidemiology of hepatitis B viral infections among drug users: seroprevalence, risk factors and viral interactions.Epidemiol Rev 1999: 16: 418\u2013436.","journal-title":"Epidemiol Rev"},{"key":"BF03169123_CR3","first-page":"128","volume":"7","author":"P Madden","year":"1997","unstructured":"Madden P, Lamagni T, Hope V. The HIV epidemic in injecting drug users.Commun Dis Rep 1997: 7: 128\u2013130.","journal-title":"Commun Dis Rep"},{"key":"BF03169123_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00002030-199102000-00001","volume":"5","author":"R Brettle","year":"1991","unstructured":"Brettle R. HIV and harm reduction for injecting drug users.AIDS 1991: 5: 125\u2013136.","journal-title":"AIDS"},{"key":"BF03169123_CR5","unstructured":"Government Strategy to prevent drug misuse. Dublin: Department of Health (Ireland), 1991."},{"key":"BF03169123_CR6","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1046\/j.1360-0443.1998.931116493.x","volume":"93","author":"R Smyth","year":"1998","unstructured":"Smyth R, Keenan E, O\u2019Connor J. Bloodborne viral infection in Irish injecting drug users.Addiction 1998: 93: 1649\u20131656.","journal-title":"Addiction"},{"key":"BF03169123_CR7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF03167717","volume":"170","author":"M Fitzgerald","year":"2001","unstructured":"Fitzgerald M, Barry J, O\u2019Sullivan P, Thornton L. Bloodborne virus infections in Dublin\u2019s opiate users.Ir J Med Sci 2001; 170:32\u201334.","journal-title":"Ir J Med Sci"},{"key":"BF03169123_CR8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmj.321.7253.78","volume":"321","author":"S Allwright","year":"2001","unstructured":"Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry J. Prevalence of antibodies to hepatitis B, hepatitis C and HIV among Irish prisoners: results of a national crosssectional survey,BMJ 2001; 321: 78\u201382.","journal-title":"BMJ"},{"key":"BF03169123_CR9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/jech.53.7.434","volume":"53","author":"B Smyth","year":"1999","unstructured":"Smyth B, Keenan E, O\u2019Connor J. Evaluation of the impact of Dublin\u2019s expanded harm reduction programmes on the prevalence of hepatitis C among injecting drug users with short injectinghistories. J Epidemiol Community Health 1999: 53: 434\u2013435.","journal-title":"histories. J Epidemiol Community Health"},{"key":"BF03169123_CR10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jech.57.4.310","volume":"57","author":"B Smyth","year":"2003","unstructured":"Smyth B, O\u2019Connor J, Barry J, Keenan E. Retrospective cohort study examining incidence of HIV and hepatitis C among injecting drug users in Dublin.J Epidemiol Community Health 2003: 57: 310\u2013311.","journal-title":"J Epidemiol Community Health"},{"key":"BF03169123_CR11","unstructured":"Introduction of hepatitis B vaccine into childhood immunization services: Management guidelines including information for health workers and parents Geneva, World Health Organization (Department of vaccines and biologicals), 2001."},{"key":"BF03169123_CR12","unstructured":"Immunisation guidelines for Ireland: National Immunisation Committee, Royal College of Physicians of Ireland, 2002."},{"key":"BF03169123_CR13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/infdis\/163.4.923","volume":"163","author":"P Mezzelani","year":"1991","unstructured":"Mezzelani P, Venturini L, Turrina G, Lugoboni F, Des Jarlais D. High compliance with a hepatitis B virus vaccination programme among intravenous drug users.J Infect Dis 1991, 163(923).","journal-title":"J Infect Dis"},{"key":"BF03169123_CR14","first-page":"174","volume":"2","author":"T Lamagni","year":"1999","unstructured":"Lamagni T, Davison K, Hope V et al. Poor hepatitis B vaccine coverage in injecting drug users: England 1995 and 1996.Commun Dis Public Health 1999: 2: 174\u2013177.","journal-title":"Commun Dis Public Health"},{"issue":"8","key":"BF03169123_CR15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1360-0443.1997.tb02979.x","volume":"92","author":"N Crofts","year":"1997","unstructured":"Crofts N, Nigro L, Oman K, Stevenson E, Sherman J. Methadone maintenance and hepatitis C virus infection among injecting drug users.Addiction 1997; 92(8): 999\u20131005.","journal-title":"Addiction"},{"key":"BF03169123_CR16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/bmj.317.7156.433","volume":"317","author":"I Beek Van","year":"1998","unstructured":"Van Beek I, Dwyer R, Dore G, Luo K, Kaldor J. Infection with HIV and hepatitis C virus infection among injecting drug users in a prevention setting: retrospective cohort study.BMJ 1998: 317: 433\u2013437.","journal-title":"BMJ"},{"key":"BF03169123_CR17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1360-0443.2001.9657177.x","volume":"96","author":"B Smyth","year":"2001","unstructured":"Smyth B, Barry J, Keenan E. Syringe borrowing persists despite harm reduction interventions.Addiction 2001: 96: 717\u2013727.","journal-title":"Addiction"},{"key":"BF03169123_CR18","unstructured":"Census 96: Principal demographic results. Dublin: Stationery Offic, 1997."},{"key":"BF03169123_CR19","volume-title":"Estimating the prevalence of opiate drug use in Dublin, Ireland during 1996. Report submitted to the Department of Health","author":"C Comiskey","year":"1998","unstructured":"Comiskey C. Estimating the prevalence of opiate drug use in Dublin, Ireland during 1996. Report submitted to the Department of Health.Department of Health. Dublin, 1998."},{"key":"BF03169123_CR20","unstructured":"National Drug Treatment Reporting System (Statistical Bulletin: National Data 1997 and 1998). Dublin, Drug Misuse Research Division (The Health Research Board), 2000."},{"issue":"1","key":"BF03169123_CR21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00042560-199802001-00004","volume":"18","author":"R Garfein","year":"1998","unstructured":"Garfein R, Doherty M, Monterosso E, Thomas D, Nelson K, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 1998; 18(Suppiement 1): 11\u201319.","journal-title":"Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology"},{"key":"BF03169123_CR22","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/ije\/26.6.1359","volume":"26","author":"K Stark","year":"1997","unstructured":"Stark K, Bienzle U, Vonk R. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among injecting drug users in Berlin.Int J Epidemiol 1997; 26: 1359\u20131366.","journal-title":"Int J Epidemiol"},{"issue":"12","key":"BF03169123_CR23","first-page":"1091","volume":"26","author":"V Grando-Lemaire","year":"2002","unstructured":"Grando-Lemaire V, Goisset P, Sorge F et al. [Hepatitis C virus screening in drug users in an addiction out-patient unit].Gastroenterol Clin Biol 2002; 26(12):1091\u20136.","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"BF03169123_CR24","first-page":"244","volume":"3","author":"M Peat","year":"2000","unstructured":"Peat M, Budd J, Burns S, Robertson R. Audit of bloodborne virus infections in injecting drug users in general practice.Commun Dis Public Health 2000; 3(4): 244\u2013246.","journal-title":"Commun Dis Public Health"},{"key":"BF03169123_CR25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/09687639997214","volume":"6","author":"B Smyth","year":"1999","unstructured":"Smyth B, McMahon J, O\u2019Connor J, Ryan J. Knowledge regarding hepatitis C among injecting drug users.Drugs Education Prevention and Policy 1999:6:256\u2013264.","journal-title":"Drugs Education Prevention and Policy"},{"key":"BF03169123_CR26","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1046\/j.1360-0443.2001.961217878.x","volume":"96","author":"P Cook","year":"2001","unstructured":"Cook P, McVeigh J, Syed O, Mutton K, Bellis M. Predictors of hepatitis B and C infection in injecting drug users both in and out of treatment.Addiction 2001:96:1787\u20131797.","journal-title":"Addiction"},{"key":"BF03169123_CR27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1464-2662.2001.00085.x","volume":"2","author":"S Clarke","year":"2001","unstructured":"Clarke S, Keenan E, Bergin C, Lyons F, Hopkins S, Mulcahy F. The changing epidemiology of HIV infection in injecting drug users in Dublin, Ireland,HIV Med 2001: 2: 236\u2013240.","journal-title":"HIV Med"},{"issue":"1","key":"BF03169123_CR28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00365549609027145","volume":"28","author":"G Rezza","year":"1996","unstructured":"Rezza G, Sagliocca L, Zaccarelli M, Nespoli M, Siconolfi M, Baldassarre C. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence.Scand J Infect Dis 1996; 28(1): 27\u20139.","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"BF03169123_CR29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1360-0443.1995.tb02189.x","volume":"90","author":"A Baker","year":"1995","unstructured":"Baker A, Kochan N, Dixon J, Wodak A, Heather N. HIV risk-taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment.Addiction 1995: 90(4): 545\u201354.","journal-title":"Addiction"},{"key":"BF03169123_CR30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/archinte.1991.00400030110020","volume":"151","author":"M Rumi","year":"1991","unstructured":"Rumi M, Colombo M, Romeo R et al. Suboptimal response to hepatitis B vaccine in drug users.Arch Intern Med 1991: 151: 574\u2013578.","journal-title":"Arch Intern Med"},{"key":"BF03169123_CR31","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1360-0443.2002.00147.x","volume":"97","author":"G Quaglio","year":"2002","unstructured":"Quaglio G, Talamini G, Lugoboni F et al. Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of vaccine response.Addiction 2002: 97: 985\u2013992.","journal-title":"Addiction"},{"key":"BF03169123_CR32","volume-title":"Vaccination guidelines for patients attending the ERHA drug treatment clinics","author":"S Keating","year":"2000","unstructured":"Keating S. Vaccination guidelines for patients attending the ERHA drug treatment clinics. Dublin, Eastern Regional Health Authority, 2000."}],"container-title":["Irish Journal of Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03169123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03169123\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03169123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T02:56:53Z","timestamp":1558493813000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03169123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["BF03169123"],"URL":"https:\/\/doi.org\/10.1007\/bf03169123","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}